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Abstract
The present work examined ex vivo the acute effect of quercetin on diabetic rat aortic ring reactivity in response to endothelium-
dependent (acetylcholine, ACh) and endothelium-independent (sodium nitroprusside, SNP) relaxants, and to the a1-adrenergic
agonist phenylephrine (PE). Responses were compared to those of aortic rings from age- and sex-matched euglycemic rats.
Compared to euglycemic rat aortic rings, diabetic rings showed less relaxation in response to ACh and SNP, and greater contraction
in response to PE. Pretreatment with quercetin (10 mM, 20 min) increased ACh-induced relaxation and decreased PE-induced
contraction in diabetic, but did not affect euglycemic rat aortic ring responses. Following pretreatment with the nitric oxide synthase
inhibitor Nv-nitro-L-arginine methyl ester (L-NAME, 10 mM), quercetin reduced PE-induced contractions in both aortic ring types,
although L-NAME attenuated the reduction in the diabetic rings. Quercetin did not alter SNP vasodilatory effects in either ring type
compared to their respective controls. These findings indicate that quercetin acutely improved vascular responsiveness in blood
vessels from diabetic rats, and that these effects were mediated, at least in part, by enhanced endothelial nitric oxide bioavailability.
These effects of quercetin suggest the possible beneficial effects of quercetin in vivo in experimental diabetes and possibly in other
cardiovascular diseases.
# 2005 Elsevier Ireland Ltd. All rights reserved.
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Endothelial cells produce several biologically active
substances that play key roles in local regulation of
blood flow, blood pressure and vascular tone, with one
of the most important being nitric oxide (NO) [1,2].
Physiological functions of endothelial cells are altered
in certain cardiovascular disease states, including
diabetes [3–5]. Diabetes is characterized by increased* Corresponding author. Tel.: +60 3 79674952;
fax: +60 3 79674791.
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doi:10.1016/j.diabres.2005.11.004oxidant stress which is believed to play an important
role in the development of vascular complications such
as reduced endothelium-dependent relaxation (EDR)
and enhanced receptor-mediated contractions asso-
ciated with diabetes [4–6]. Indeed, recent studies have
shown that short-term in vitro and long-term in vivo
antioxidant interventions improved endothelial function
in diabetes [6,7], suggesting a pathological role for
oxygen-derived free radicals in the impaired vascular
responses in diabetes.
Flavonoid-rich diets are reported to have beneficial
effects in cardiovascular disease states associated with
overproduction of reactive oxygen species. For exam-
ple, the Rotterdam study showed an inverse associationserved.
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infarction [8]. These protective effects of flavonoids are
chiefly ascribed to their antioxidant and vasodilator
actions [9,10]. Quercetin, the most commonly found
flavonoid in the human diet, has been shown to exert
potent free radical scavenging and antioxidant actions,
to cause vasodilatation in isolated vascular preparations,
and to elicit blood glucose-lowering (anti-diabetic)
effects in experimental diabetes [11–15]. In addition,
we and others have demonstrated the endothelial
protective effects of chronic quercetin in experimental
hypertension [16,17]. However, to our knowledge there
is no information available about the effects of
quercetin on impaired vascular reactivity of diabetic
arteries.
Using aortic rings isolated from streptozotocin
(STZ)-induced diabetic rat, in the present work,
therefore, we investigated whether quercetin could
acutely modulate relaxant and contractile responses in
diabetic blood vessels.2. Materials and methods
2.1. Drugs and chemicals
Quercetin, phenylephrine-HCl (PE), acetylcholine chlor-
ide (ACh), indomethacin, v-nitro-L-arginine methyl ester (L-
NAME), and streptozotocin (STZ) were purchased from
Sigma Chemicals Company (St. Louis, MO, USA). Sodium
nitroprusside (SNP) and Krebs salts were purchased from
BDH Limited and BDH Laboratory Supplies (Poole, UK),
respectively. Except for quercetin, all the other drug solutions
were prepared fresh on the day of experiment by dissolving
weighed amounts of respective drugs in distilled water. Quer-
cetin stock solution (10 mM) was prepared in 5% (v/v)
dimethyl sulfoxide (DMSO). The final concentrations were
prepared by serial dilutions with distilled water and the final
concentration of DMSOwas adjusted to less than 0.05% (v/v).
2.2. Experimental animals
The animals were obtained from the University of Malaya
animal unit, and all the experimental procedures were per-
formed in accordance with guidelines issued by the University
of Malaya Animal Experimentation Ethics Committee. Male
Wistar-Kyoto (WKY) rats, aged about 12–13 weeks, were
divided randomly into two groups, each comprising of 15
animals. The rats were maintained under controlled room
conditions and supplied with standard rat chow and tap water
ad libitium. After 1 week of acclimatization period, diabetes
was induced in one group of rats by a single intraperitoneal
dose (75 mg/kg) of STZ dissolved in cold normal saline.
Plasmatic glycemia was examined 3 days after diabetes
induction and the rats were considered as diabetics only iftheir blood glucose level exceeds 17 mmol/l. The rats were
then maintained at the specified conditions for 8 weeks prior to
being sacrificed at the age of 20–21 weeks.
2.3. Measurement of ex vivo vascular function
The diabetic and control euglycemic rats were anaesthe-
tized with pentobarbital (60 mg/kg, IP). The descending thor-
acic aorta was excised by midline incision, cleaned of fat and
connective tissues, with care taken not to stretch the vessel
excessively or to disturb the luminal surface of the rings, to
ensure the integrity of the endothelium. The aorta was then cut
into small rings (3–5 mm in width) and suspended between
two wire stirrups in a jacketed organ bath containing 5 ml of
normal Krebs physiological solution (KPS) of the following
composition (mM): NaCl 118.2, KCl 4.7, CaCl22H2O 2.5,
KH2PO4 1.2, MgCl2 1.2, glucose 11.7, NaHCO3 25.0, and
EDTA 0.026. The bath solution was maintained at 37 8C and
oxygenated continuously with a mixture of 95% oxygen and
5% carbon dioxide. The rings were then progressively
stretched to a preload tension of 1 g and allowed to equilibrate
for 45 min. During this period the bath solution was replaced
every 15 min. Following the equilibration period, aortic rings
were exposed twice (each for 5 min) to isotonic potassium
chloride solution (high K+, 80 mM). After washout of
responses to high K+, the relaxation responses to ACh and
SNP or contractile responses to PE were recorded in the aortic
rings. Indomethacin (10 mM) was added to the bath for all the
experiments to inhibit the synthesis of endoperoxides includ-
ing the prostaglandins [7]. Aortic rings from diabetic and age-
matched euglycemic rats were incubated for 20 min in KPS to
which was added quercetin (10 mM) or its vehicle (DMSO).
Preliminary studies showed that quercetin or its vehicle did
not modify basal tension of aortic rings from both euglycemic
and diabetic rats during the time course of incubation before
addition of agonists. The choice of 10 mM quercetin in this
study is based on previous studies in which this concentration
was found to induce endothelium and nitric oxide (NO)-
dependent (against PE-induced contraction) and endothe-
lium-independent (against high K+-induced contraction)
relaxation in isolated euglycemic [13] and diabetic [15] rat
aortas.
2.3.1. Relaxations to ACh and SNP
The relaxations to ACh and SNP were examined in PE-
precontracted aortic rings. The rings were exposed to single
concentration of PE (1 mM) and at the peak of the contraction
the relaxations to cumulatively increasing concentrations of
ACh (0.1 nM–10 mM) or SNP (10 pM–1 mM) were recorded
at 3 min intervals.
2.3.2. Contractile responses to PE
The responses of the aortic rings to cumulatively increasing
concentrations of PE (0.1 nM–10 mM) were recorded at inter-
vals of 3 min. The protocol was repeated with a separate set of
diabetic and euglycemic aortic rings which were exposed to the
nitric oxide synthase inhibitor, L-NAME (10 mM).
M. Ajay et al. / Diabetes Research and Clinical Practice 73 (2006) 1–7 32.4. Calculations and statistical analysis
Relaxation responses to cumulative concentrations of ACh
and SNP were calculated as percentage inhibition of PE-
induced maximal contraction. Concentration-dependent con-
tractile responses to PE were recorded as percentage of the
maximum contraction obtained following tissue stimulation
with high K+. All the results were given as mean  standard
error of the mean (S.E.M.). The concentration–response
curves for each experimental condition was plotted and from
it was deduced the maximum agonist-induced response and
the pEC50 (negative logarithm of median concentration)
values. The differences in responses among the different
groups were analyzed for statistical significance using two-
tailed Student’s t-test for unpaired observations and one-way
analysis of variance (ANOVA, Prism version 2.0, GraphpadFig. 1. Effects of quercetin (10 mM) on endothelium-dependent relaxation r
(B) diabetic rats. Symbols represent mean  S.E.M. (n = 6 or 7). #p < 0.05
quercetin vs. vehicle pretreated diabetic aorta.
Table 1
Effects of quercetin on vascular reactivity of aortic rings of euglycemic an
Rats Treatment group Phenylephrine (PE)
Maximum
contraction (%)
pEC50
Euglycemic Vehicle 126.2  8.0 7.07  0.1
Quercetin 136.6  5.5 6.84  0.09
L-NAME + vehicle 178.8  5.3a 9.02  1.5
L-NAME + quercetin 151.3  6.7b 8.68  1.6
Diabetic Vehicle 148.9  9.0a 7.17  0.1
Quercetin 80.0  10.8a,c 6.99  0.2
L-NAME + vehicle 176.9  10.4c 7.27  0.1
L-NAME + quercetin 126.8  7.1b 7.12  0.2
The aortic rings were pretreated with quercetin (10 mM) or vehicle (DMSO
a p < 0.05 vs. vehicle pretreated euglycemic aortas.
b p < 0.05 vs. corresponding L-NAME plus vehicle pretreated aortas.
c p < 0.05 vs. vehicle pretreated diabetic aortas.Software, USA) for dose–response curves. In all cases the
differences were considered significant only if the p value was
less than 0.05.
3. Results
3.1. ACh- and SNP-induced relaxation
We examined ACh-induced relaxation in isolated
aortic rings from euglycemic and diabetic rats in the
presence of vehicle or quercetin (Fig. 1). Euglycemic
aortic rings showed a dose-dependent relaxation in
response to ACh, with a pEC50 value of 7.75 and a
maximum relaxation (Rmax) of 87% in terms of the
reduction in the peak PE-induced contraction (Table 1).esponses to acetylcholine (ACh) in aortic rings of (A) euglycemic and
for diabetic aorta vs. corresponding euglycemic aorta; *p < 0.05 for
d STZ-induced diabetic rats
Acetylcholine (ACh) Sodium nitroprusside (SNP)
Maximum
relaxation (%)
pEC50 Maximum
relaxation (%)
pEC50
86.9  4.8 7.75  0.2 104.0  1.0 7.68  0.2
91.0  4.3 7.70  0.1 104.8  1.7 7.98  0.1
ND ND ND ND
ND ND ND ND
64.1  5.1a 6.91  0.2 95.84  1.4a 7.30  0.4
85.0  2.6 7.39  0.2 97.61  2.4 7.46  0.4
ND ND ND ND
ND ND ND ND
). ND: not determined.
M. Ajay et al. / Diabetes Research and Clinical Practice 73 (2006) 1–74
Fig. 2. Effects of quercetin (10 mM) on endothelium-independent relaxation responses to sodium nitroprusside (SNP) in aortic rings of (A)
euglycemic and (B) diabetic rats. Symbols represent mean  S.E.M. (n = 6).Quercetin pre-treatment had no significant effect on the
vasorelaxant responses to ACh (pEC50 = 7.70,
Rmax = 91%) (Fig. 1A). In diabetic aortic rings, the
Rmax for the ACh response was markedly reduced to
64% and the curve shifted to the right compared to the
euglycemic aortic rings curve (Fig. 1). Quercetin
pretreatment of diabetic rings improved the relaxant
response to ACh and cause a leftward shift of the dose–
response curve compared to vehicle pretreated aortic
rings (Fig. 1B). This improvement in the vasorelaxant
response of the diabetic rings to ACh was similar to that
for euglycemic aortic rings.
Fig. 2 shows the result of relaxations induced by SNP
in aortic rings from the various experimental groups.
The relaxation curves for SNP for the various groupsFig. 3. Effects of quercetin (10 mM) on contractile responses to phenylephrin
represent mean  S.E.M. (n = 6 or 7). #p < 0.05 for diabetic aorta vs. corresp
diabetic aorta.were similar, other than a significant reduction in the
peak relaxation recorded for the control diabetic rings
compared to the equivalent euglycemic aortic rings
(Table 1).
3.2. PE-induced contraction
We examined aortic ring contractions in response
to increasing concentrations of PE (Fig. 3). Eugly-
cemic aortic rings showed concentration-dependent
contraction with a pEC50 value of 7.07 and a
maximum contractile response (Cmax) of 126% of
the high K+-induced contraction (Table 1). Quercetin
pretreatment had little effect on these contractile
responses (Cmax = 136%, pEC50 = 6.84). In diabetice (PE) in aortic rings of (A) euglycemic and (B) diabetic rats. Symbols
onding euglycemic aorta; *p < 0.05 for quercetin vs. vehicle pretreated
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Fig. 4. Effects of quercetin (10 mM) on contractile responses to phenylephrine (PE) in the presence of L-NAME in aortic rings of (A) euglycemic and
(B) diabetic rats. Symbols represent mean  S.E.M. (n = 6 or 7). *p < 0.05 for quercetin vs. vehicle pretreated euglycemic aorta; #p < 0.05 for
quercetin vs. vehicle pretreated diabetic aorta.aortic rings, addition of PE resulted in contraction
with a pEC50 value of 7.17 and a higher Cmax response
of 149% compared to euglycemic rings. Pretreatment
of the diabetic rings with quercetin markedly reduced
the responses to PE (Cmax = 84%, pEC50 value of
6.99).
To ascertain the involvement of nitric oxide in the
response to quercetin, we examined the effect of the
endothelial nitric oxide synthase inhibitor, L-NAME.
Compared to their respective vehicle incubated control
rings, the addition of L-NAME to the incubation mixture
increased the Cmax response to PE (Fig. 4). For both
euglycemic and diabetic rings, the addition of quercetin
to the incubation mixture containing L-NAME caused
the contractile response curves for PE to shift down-
wards of those generated from L-NAME alone incuba-
tions. However, the percentage depression of the Cmax
response to PE in diabetic rings was less in L-NAME-
treated diabetic rings (50%) compared to vehicle
control-treated diabetic aortic rings (68%) (Table 1).
4. Discussion
A major finding of the current work was that
quercetin acutely increased ACh-induced endothelium-
dependent relaxation, and reduced a1-adrenergic
stimulant PE-induced contraction in diabetic rat aortic
rings ex vivo, but did not have such effects in
euglycemic rat aortic rings. In addition, L-NAME
attenuated the vasodepressor effects of quercetin on PE-
induced diabetic rat aortic ring contractions. Further-
more, quercetin reduced PE-induced contractions in L-
NAME-pretreated euglycemic rat aortic rings.Previous studies have reported that various vascular
preparations from diabetic animals show reduced
relaxation in response to the endothelium-dependent
and -independent vasodilators ACh and SNP, respec-
tively, and enhanced contractions in response to the a1-
adrenergic stimulant PE [3,18–20]. Increased produc-
tion of free radicals including superoxide anions has
been implicated in these processes [3–7]. Superoxide
anions might inhibit endothelial relaxation or enhance
receptor-mediated contractions either by enhancing
vascular smooth muscle contraction or by inactivating
endothelium-derived nitric oxide [6,19,21,22].
Acute activation of endothelial nitric oxide synthase
(eNOS) by ACh results in synthesis/release of
endothelial nitric oxide, which in turn leads to guanyl
cyclase activation, cGMP elevation and ultimately to
vascular smooth muscle relaxation. In diabetic rat aortic
rings, quercetin pretreatment increased ACh-induced
relaxation but had no effect on the response to SNP.
Therefore, the effect of quercetin on ACh-induced
relaxation in diabetic rat aortic rings is unlikely to be
due to a non-specific general improvement in vascular
reactivity (e.g. activation of the endothelial nitric oxide–
cGMP relaxant pathway or enhanced cGMP produc-
tion) [19,23]. The present data suggest quercetin-
enhanced ACh-induced relaxation in diabetic rat aortic
rings was dependent on endothelium-derived nitric
oxide. Recent data suggest the beneficial vascular
effects of flavonoids are closely related to their free
radical scavenging and antioxidant properties. Querce-
tin is a potent antioxidant and has been shown
previously to protect nitric oxide from the scavenging
actions of the superoxide anion [11,12,24,25]. Given
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relaxation of diabetic arteries to ACh [3–7], the free
radical scavenging action may explain the effects of
quercetin on ACh-induced relaxation in diabetic rat
aortic rings in the present study. We also found that
whereas quercetin restored ACh responses in diabetic
rat aortic rings, it had no effect on ACh responses in
euglycemic rat aortic rings, where the production of
superoxide anions has been thought to be too little to
alter the bioavailability of endothelium-derived nitric
oxide. This finding also suggests that the effects of
quercetin were more pronounced when bioavailability
of EDNO is impaired. Furthermore, quercetin restored
ACh-induced relaxation in diabetic rat aortic rings to
levels similar to those observed in euglycemic rat aortic
rings. These observations further support our conten-
tion that quercetin improved ACh responses in diabetic
rat aortic rings through its free radical scavenging
actions.
The present results showed that quercetin had no
effect on PE-induced contraction in euglycemic aortic
rings, but significantly reduced in diabetic aortic rings.
Quercetin caused a relaxation through endothelium-
derived nitric oxide and prostacylin-pathways and/or
decrease in intracellular calcium availability in smooth
muscle cells in pre-contracted aortic rings isolated from
euglycemic [13] and diabetic [15] rats. The present
study involved the use of indomethacin, a cyclo-
oxygenase inhibitor, in the organ chamber throughout
the experiments, making it unlikely there was any
relaxing effect from endothelium-derived prostacyclin
or cross-talk between EDNO signaling pathways and
prostanoids. In addition, the latter studies also reported
that the pretreatment with quercetin was without any
inhibitory effects on the contractions induced by PE in
isolated euglycemic and diabetic rat aortic rings
[13,15]. These results suggest that pretreatment with
quercetin does not modify basal levels of endothelium-
derived relaxant factors (EDRF) or modify calcium
influx in both types of aortic rings. On the other hand, it
is also reported that the vasoconstrictor effect of a-
adrenergic receptor agonists can be modulated by
EDRF released by activation of a-adrenoreceptor on the
endothelial membrane [26]. Taking these previous
reports into consideration, the present results indicate a
possible involvement of free radical scavenging activity,
i.e., protection of EDRF released by activation of
endothelial a-adrenoreceptor, in the quercetin attenua-
tion of PE contraction of diabetic aortic rings. Two
findings from the present study support this hypothesis.
First, the vasodepressor effects of quercetin on PE-
induced diabetic rat aortic ring contraction wereattenuated by L-NAME, suggesting the quercetin effect
was mediated, at least in part, by EDNO. Second,
quercetin did not affect PE-induced contractions in
euglycemic rat aortic rings.
The present study found that PE-induced contractions
were lower in quercetin-pretreated diabetic rat aortic
rings compared to euglycemic rat aortic rings. Further-
more, quercetin reduced PE responses in L-NAME-
pretreated euglycemic and diabetic rat aortic rings. These
findings that quercetin can act in the partial or complete
absence of EDNO bioavailability suggest quercetin can
exert its vasodepressor effects via mechanisms other
than, or in addition to, those involving free radical
scavenging and antioxidant protective effects on EDNO.
Flavonoids have been recently reported to elicit
endothelium-derived hyperpolarizing factor (EDHF)-
mediated vascular reactivity in vascular preparations
[27,28]. The present experimental conditions inhibiting
endothelial nitric oxide- and prostacyclin-mediated
vasodilatation suggest the observed vasodepressor effect
of quercetin may have involved EDHF. However, this
assumption requires conformation. In addition, it is
conceivable that the effects of quercetin would be much
more pronounced when the bioavailability of EDNO is
impaired since the attenuation by quercetin of PE
contraction in rings from normal rats was not observed in
the absence of L-NAME.
In summary, the present results show, for the first
time, that quercetin restores endothelium-dependent
vascular relaxation and reduces agonist-mediated
constriction in aortas isolated from experimental
diabetic rats. These beneficial actions of quercetin
were mediated, at least in part, by its antioxidant
protection of endothelium-derived nitric oxide. These
acute effects of quercetin involving increased endothe-
lium-dependent relaxation and reduced receptor-
mediated contraction suggest mechanisms explaining
the possible beneficial effects of quercetin in vivo in
experimental diabetes and possibly in other cardiovas-
cular diseases.
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